New clues point to relief for chronic itching

April 17, 2018, Washington University School of Medicine
Credit: CC0 Public Domain

A common side effect of opioids is intense itching—a problem for some patients who need the drugs for pain relief and for others fighting addiction.

Now, studying mice, researchers at Washington University School of Medicine in St. Louis have found that a drug called nalfurafine hydrochloride can deliver itch relief by targeting particular opioid on neurons in the . The drug (brand name Remitch) is approved in Japan to alleviate itching in dialysis patients with and in patients with severe liver disease. The drug also is being tested for its anti-itch effects in the U.S., but until now scientists haven't understood how it works.

The new study suggests that the drug may be effective against many types of that don't respond to conventional drugs such as antihistamines. The drug targets what's known as kappa opioid receptors on neurons in the spinal cord. While other receptors on the same neurons can ramp up itching, this study shows that activating the kappa receptor significantly dials down itching.

The findings are published April 17 in the journal Cell Reports.

"The activate a pathway that tamps down the activity of GRPR, which our lab previously identified as the first itch gene," said senior investigator Zhou-Feng Chen, PhD, director of the Center for the Study of Itch at Washington University School of Medicine in St. Louis. "This gene relays itch signals from the spine to the brain."

Credit: Washington University School of Medicine

Chen, the Russell D. and Mary B. Shelden Professor of Anesthesiology, and his colleagues studied mice treated with a substance to make them feel itchy. Others had been genetically engineered to develop chronic itching. When the researchers injected the directly into the spinal cords of the animals, their scratching was markedly reduced.

Chen's team found that about half of the neurons in the spinal cord that transmit itch signals have kappa , and when those receptors are activated, they inhibit GRPR.

It may not be practical to administer spinal cord injections of drugs to patients with chronic itch—whatever the cause—but now that the researchers have identified a way to alleviate such itching, they can try to activate the same receptor in other ways. Or, Chen said, they may target some of the downstream molecules that are activated when the kappa receptor is targeted.

"Some molecules downstream from the kappa receptor may still be able to tamp down itching without causing any unwanted side effects that may occur when drugs activate the kappa receptor in parts of the body outside of the spinal cord," explained Chen, who also is a professor of psychiatry and of developmental biology.

His team is working to learn whether those strategies will work in mice, with the hope that the same molecules eventually may become therapeutic targets in people with chronic itch.

Explore further: Neuroscience: Why scratching makes you itch more

More information: Munanairi A, Liu X-Y, Barry DM, Yang Q, Yin J-B, Jin H, Li H, Meng Q-T, Peng J-H, Wu Z-Y, Yin J, Zhou X-Y, Wan L, Mo P, Kim S, Huo F-Q, Jeffry J, Li Y-Q, Bardoni R, Bruchas MR and Chen Z-F. Non-canonical opioid signaling inhibits itch transmission in the spinal cord of mice. Cell Reports. April 17, 2018.

Related Stories

Neuroscience: Why scratching makes you itch more

October 30, 2014
Turns out your mom was right: Scratching an itch only makes it worse. New research from scientists at Washington University School of Medicine in St. Louis indicates that scratching causes the brain to release serotonin, ...

Potential new target identified for treating itch

July 19, 2016
Researchers have found how sensory nerve cells work together to transmit itch signals from the skin to the spinal cord, where neurons then carry those signals to the brain. Their discovery may help scientists find more effective ...

Scientists unravel mechanisms in chronic itching

October 15, 2013
Anyone who has suffered through sleepless nights due to uncontrollable itching knows that not all itching is the same. New research at Washington University School of Medicine in St. Louis explains why.

Scientists identify central neural circuit for itch sensation

August 17, 2017
Itching is an unpleasant sensation associated with the desire to scratch, and the itch sensation is an important protective mechanism for animals. However, chronic itch, often seen in patients with skin and liver diseases, ...

Recommended for you

Enduring cold temperatures alters fat cell epigenetics

April 19, 2018
A new study in fat cells has revealed a molecular mechanism that controls how lifestyle choices and the external environment affect gene expression. This mechanism includes potential targets for next-generation drug discovery ...

Leptin's neural circuit identified—Genome-editing study reveals how hormone helps prevent both obesity and diabetes

April 18, 2018
Revealing surprising answers to a long-standing enigma about the brain target of the anti-obesity hormone leptin, neuroscientists at Tufts University School of Medicine have used CRISPR genome editing to identify a neural ...

Characterizing 'keyhole' is first step to fighting obesity at cellular level

April 18, 2018
An international team has uncovered the potential to beat obesity at the cellular level, characterizing for the first time a complex, little-understood receptor type that, when activated, shuts off hunger.

Why is it harder for females to gain weight?

April 18, 2018
For years, scientists have observed that when male and female mice eat the same high-fat diet, the males gain significantly more weight than the females. The reasons for this difference between sexes are not completely understood, ...

Researchers succeed in cultivating cartilage from stem cells

April 17, 2018
Researchers have produced stable joint cartilage from adult stem cells originating from bone marrow. This was made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers ...

Researchers develop new process to differentiate stem cells

April 17, 2018
Neck and back pain are debilitating and expensive: an estimated 80 percent of adults will suffer one or both at some point during their lives, racking up $86 billion in medical costs and missed work in the United States alone. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.